Product Name | MF | CAS | Details |
---|
Tyrosinase-IN-10 | C16H12O4 | 2873418-48-3 | Details |
Aeruginosin 98-B | C29H46N6O9S | 167228-01-5 | Details |
p53 Activator 3 | C30H37F3N4O4S | 2636839-90-0 | Details |
IDH1 Inhibitor 7 | C22H24F3N7O | 2135309-56-5 | Details |
3-epi-Vitamin D3 | C27H44O | 57651-82-8 | Details |
Massarilactone H | C11H12O5 | 1393110-39-8 | Details |
(R)-eIF4A3-IN-2 | C25H19Br2ClN4O2 | 2095484-82-3 | Details |
GPR81 agonist 2 | C26H27ClN6O5S2 | 1143024-28-5 | Details |
E7090 succinate | C36H43N5O10 | 1879965-80-6 | Details |
P-gp inhibitor 2 | C29H26N2O6 | 2408406-89-1 | Details |
Sinulatumolin E | C15H22O2 | 2570255-85-3 | Details |
Huanglongmycin N | 2881024-09-3 | Details |
(R)-Casopitant | C30H35F7N4O2 | 414910-26-2 | Details |
Telomerase-IN-5 | 2892295-16-6 | Details |
MNK inhibitor 9 | C25H29N9O | 1889336-59-7 | Details |
(±)-Hydnocarpin | C25H20O9 | 298704-61-7 | Details |
EphA2 agonist 2 | C40H56N10O6 | 2169273-66-7 | Details |
YCT529 free acid | C29H25NO3 | 2863670-66-8 | Details |
D-threo-PDMP | C23H38N2O3 | 109836-82-0 | Details |
Naloxonazine | C38H44Cl2N4O6 | 82824-01-9 | Details |
Misetionamide | C3H7NO3S | 856785-75-6 | Details |
PI3K/AKT-IN-2 | C32H27BrO10 | 2684412-41-5 | Details |
IMD-vanillin | 2928463-38-9 | Details |
18:0-22:6 DG | C43H72O5 | 65886-80-8 | Details |
TNKS1/2-IN-1 | C26H23F4N3O4 | 1498300-31-4 | Details |
Norswertianin | C13H8O6 | 22172-15-2 | Details |
Artemisiane E | C20H22O5 | 2618700-77-7 | Details |
Autotaxin-IN-6 | 2800898-98-8 | Details |
EGFR/HER2-IN-9 | C25H25ClFN5O4 | 1637253-79-2 | Details |
(+)-Cembrene A | C20H32 | 72691-72-6 | Details |
PBRM1-BD2-IN-6 | C16H15ClN2O | 2819989-67-6 | Details |
Gly-7-MAD-MDCPT | C24H22N4O7 | 2378427-68-8 | Details |
Coleon-U-quinone | C20H24O5 | 65714-83-2 | Details |
CBP/p300-IN-10 | C25H24F5N5O3 | 2259641-71-7 | Details |
TLR8 agonist 5 | C31H40N6O5 | 2413016-41-6 | Details |
Nrf2 activator-6 | C31H37ClFN5O5 | 2728780-74-1 | Details |
(S)-Erypoegin K | C20H18O6 | 2055053-90-0 | Details |
Tyrosinase-IN-7 | C15H10O5 | 2873418-52-9 | Details |
PD-1/PD-L1-IN-28 | C24H24N4O2 | 2499965-07-8 | Details |
Acipimox sodium | C6H7N2NaO3 | 76958-97-9 | Details |
α-Amylase-IN-2 | C39H52BrNO4 | 2758286-53-0 | Details |
Clathrin-IN-2 | C17H18Br2N2O | 2650733-69-8 | Details |
IMD-biphenylC | 2928463-42-5 | Details |
Telomerase-IN-4 | 2892295-10-0 | Details |
IMD-catechol | 2928463-39-0 | Details |
PKCiota-IN-1 | C25H22FN5O | 2230052-97-6 | Details |
IMD-biphenylB | 2928463-41-4 | Details |
Indolokine A4 | C13H10N2O3S | 1809317-07-4 | Details |
Triphen diol | C22H20O4 | 1213777-80-0 | Details |
PD-1/PD-L1-IN-30 | C29H28F3NO5 | 2171558-14-6 | Details |
Pildralazine | C8H15N5O | 64000-73-3 | Details |
ADAMTS-5-IN-2 | C17H15N3OS | 294648-66-1 | Details |
IMD-biphenylA | 2928463-40-3 | Details |
JNK3 inhibitor-4 | C28H27N7O | 2409109-65-3 | Details |
sEH/AChE-IN-2 | C30H33ClF3N5O3 | 2490589-09-6 | Details |
Cavα2δ1&NET-IN-1 | C23H26N4O2S | 2314361-39-0 | Details |
Geissoschizoline | C19H26N2O | 18397-07-4 | Details |
JNK3 inhibitor-3 | 2873465-25-7 | Details |
trans-ccc_R08 | C22H19ClO6 | 2413192-49-9 | Details |
(Rac)-Lonafarnib | C27H31Br2ClN4O2 | 193275-86-4 | Details |
MDM2-p53-IN-16 | C32H33N3O5 | 1917350-09-4 | Details |
sEH inhibitor-14 | 2890221-26-6 | Details |
Sofnobrutinib | C26H23FN8O2 | 1646608-10-7 | Details |
c-Met/HDAC-IN-3 | C34H35FN4O7 | 2439175-23-0 | Details |
Keap1-Nrf2-IN-13 | C28H32N2O10S2 | 2456294-92-9 | Details |
CDK4/6-IN-15 | C21H27FN8S | 2078047-99-9 | Details |
Tyrosinase-IN-11 | C15H14O5 | 240797-64-2 | Details |
NR2F1 agonist 1 | C28H30N4OS | 374101-64-1 | Details |
HDAC/BET-IN-1 | 2757573-68-3 | Details |
Ganoderic acid R | C34H50O6 | 103963-39-9 | Details |
SHP2/CDK4-IN-1 | 2924036-87-1 | Details |
Cavα2δ1&NET-IN-3 | C24H30N6O2S | 2143584-82-9 | Details |
p53 Activator 5 | C29H32F6N4O | 2636840-37-2 | Details |
Azaphilone-9 | C21H23BrO5 | 1448460-87-4 | Details |
Norartocarpetin | C15H10O6 | 520-30-9 | Details |
RAGE/SERT-IN-1 | 2766739-35-7 | Details |
JAK2/STAT3-IN-1 | C34H35BrF3N5O2 | 2485758-50-5 | Details |
Akt1&PKA-IN-1 | C20H17Cl2N3O | 1334107-58-2 | Details |
SHP2/HDAC-IN-1 | C34H35Cl2N7O3 | 2831230-38-5 | Details |
UCK2 Inhibitor-1 | C27H21N3O4S | 902289-98-9 | Details |
sEH/AChE-IN-4 | C35H39ClF3N5O3 | 2490589-12-1 | Details |
sEH/AChE-IN-3 | C35H39ClF3N5O3 | 2490589-11-0 | Details |
Cavα2δ1&NET-IN-2 | C22H26N6O2S | 2143586-17-6 | Details |
(R)-TTBK1-IN-1 | C18H19N5O2 | 2735015-59-3 | Details |
PBRM1-BD2-IN-1 | C17H19ClN2O | 1915012-21-3 | Details |
CB2R agonist 1 | C22H32N2O | 1817633-49-0 | Details |
c-Met/HDAC-IN-2 | C34H33N5O7 | 2740495-53-6 | Details |
Akt1&PKA-IN-2 | C20H17Cl2N3O | 1334108-00-7 | Details |
AChE/BuChE-IN-1 | C19H19NO4 | 84212-49-7 | Details |
Ras modulator-1 | C29H21N5O4S | 623935-08-0 | Details |
Tubulin/MMP-IN-2 | C40H48NO11P | 2734877-51-9 | Details |
11β-HSD1-IN-9 | C13H9F3N2O | 88283-34-5 | Details |
D-Isofloridoside | C9H18O8 | 23202-76-8 | Details |
PD-1/PD-L1-IN-29 | C26H24N2O6 | 2665734-13-2 | Details |
(R)-PF-06256142 | C21H16N4O2 | 1609583-15-4 | Details |
EGFR/C797S-IN-1 | C28H30N4O3 | 2378188-21-5 | Details |
EGFR/CDK2-IN-1 | C19H12BrClO2 | 2841405-96-5 | Details |
(R)-Olacaftor | C29H34FN3O4S | 1899111-41-1 | Details |
Dosimertinib-d3 | C28H33N7O2 | 2403760-70-1 | Details |
FSHR agonist 1 | C26H33N3O3S | 1256776-89-2 | Details |
Product Total: Product Page: | ||||
19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 |